Cytokine Signalling Forum
Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
- Autore: Vários
- Narratore: Vários
- Editore: Podcast
- Durata: 0:10:25
- Altre informazioni
Informações:
Trama
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, he discusses two papers: risk of MACE in patients with RA treated with JAKis compared to bDMARDs from the “JAK-pot” study, and the efficacy and safety of zimlovisertib, ritlecitinib and tofacitinib, alone and in combination, in patients with RA and an inadequate response to MTX.
